Malignant melanoma: Incidence issues and their effect on diagnosis and treatment in the 1990s

Mayo Clinic Proceedings

Volumn 72, Issue 4, 1997, Pages 367-371

  Rigel, Darrell S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CONFERENCE PAPER; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MELANOMA; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; SKIN CANCER;

EID: 0031421554     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/72.4.367     Document Type: Conference Paper

References (35)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. ÇA Cancer J Clin 1996; 46:5-27
2. Salopek TG, Marghoob AA, Slade JM, Rao B, Rigel DS, Kopf AW, et al. An estimate of the incidence of malignant melanoma in the United States: based on a survey of mem-bers of the American Academy of Dermatology. Dermatol Surg 1995; 21:301-305
3. Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996; 34:839-847
4. Kopf AW, Rigel DS, Friedman RJ. The rising incidence and mortality rate of malignant melanoma. J Dermatol Surg Oncol 1982; 8:760-761
5. Rigel DS, Kopf AW, Friedman RJ. The rate of malignant melanoma in the United States: are we making an impact? J Am Acad Dermatol 1987; 17:1050-1053
6. Melia J, Frost T, Graham-Brown R, Hunter J, Marsden A, du Vivier A, et al. Problems with registration of cutaneous malignant melanoma in England. BrJ Cancer 1995; 72:224228
7. Roberts DL. Accuracy of local data on skin cancer: skin cancer registry data may greatly underestimate cases [letter]. BMJ 1995; 310:1327
8. Koh HK, Clapp RW, Barnett JM, Nannery WM, Tahan SR, Geller AC, et al. Systematic underreporting of cutaneous malignant melanoma in Massachusetts: possible implications for national incidence figures. J Am Acad Dermatol 1991; 24:545-550
9. Devesa SS, Silverman DT, Young JL Jr, Pollack ES, Brown CC, Horm JW, et al. Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst 1987; 79:701-770
10. Wender RC. Barriers to effective skin cancer detection. Cancer 1995; 75(Suppl 2):691-698
11. van der Esch EP, Muir CS, Nectoux J, Macfarlane G, Maisonneuve P, Bharucha H, et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 1991; 47:483489
12. Balch CM, Soong SJ, Shaw HM, Urist MM, McCarthy WH. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ, editors. Cutaneous Melanoma. 2nd ed. Philadelphia: Lippincott, 1992: 165-187
13. Herd RM, Cooper EJ, Hunter JA, McLaren K, Chetty U, Watson AC, et al. Cutaneous malignant melanoma: publicity, screening clinics and survival-the Edinburgh experience 1982-90. BrJDermatol 1995; 132:563-570
14. Burton RC, Coates MS, Hersey P, Roberts G, Chetty MP, Chen S, et al. An analysis of a melanoma epidemic. Int J Cancer 1993; 55:765-770
15. Rigel DS. Identification of those at highest risk for development of malignant melanoma. Adv Dermatol 1995; 10:1 SI170
16. Friedman RJ, Rigel DS, Silverman MK, Kopf AW, Vossaert KA. Malignant melanoma in the 1990s: the continued importance of early detection and the role of physician examination and self-examination of the skin. CA Cancer J Clin 1991;41:201-226
17. Slue W, Kopf AW, Rivers JK. Total-body photographs of dysplastic nevi. Arch Dermatol 1988; 124:1239-1243
18. Binder M, Schwarz M, Winkler A, Steiner A, Kaider A, Wolff K, et al. Epiluminescence microscopy: a useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol 1995; 131:286-291
19. Green A, Martin N, Pfitzner J, O'Rourke M, Knight N. Computer image analysis in the diagnosis of melanoma. J Am Acad Dermatol 1994; 31:958-964
20. Rigel DS, Rogers GS, Friedman RJ. Prognosis of malignant melanoma. Dermatol Clin 1985 Apr; 3:309-314
21. Clark WH Jr, Elder DE, Guerry D IV, Braitman LE, Trock BJ, Schultz D, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989:81:1893-1904
22. Friedman RJ, Rigel DS, Kopf AW, Grin CM, Heilman E, Bart RS, et al. Volume of malignant melanoma is superior to thickness as a prognostic indicator: preliminary observation. Dermatol Clin 1991 Oct; 9:643-648
23. Salopek TG, Slade JM, Marghoob AA, Rigel DS, Kopf AW, Bart RS, et al. Management of cutaneous malignant mêla-noma by dermatologists of the American Academy of Dermatology. I. Survey of biopsy practices of pigmented lesions suspected as melanoma. J Am Acad Dermatol 1995; 33:441450
24. Lederman JS, Sober AJ. Does wide excision as the initial diagnostic procedure improve prognosis in patients with cutaneous melanoma? J Dermatol Surg Oncol 1986; 12:697-699
25. NIH Consensus Development Panel on Early Melanoma. Diagnosis and treatment of early melanoma. JAMA 1992; 268:1314-1319
26. Veronesi U, Cascinelli N. Narrow excision ( 1 -cm margin): a safe procedure for thin cutaneous melanoma. Arch Surg 1991; 126:438-441
27. Lyons JH III, Cockerell CJ. Elective lymph node dissection for melanoma. J Am Acad Dermatol 1994; 30:467-480
28. Godellas CV, Berman CG, Lyman G, Cruse CW, Rapaport D, Heller R, et al. The identification and mapping of melanoma regional nodal métastases: minimally invasive surgery for the diagnosis of nodal métastases. Am Surg 1995; 61:97-101
29. Glass LF, Fenske NA, Messina JL, Cruse CW, Rapaport DP, Berman C, et al. The role of selective lymphadenectomy in the management of patients with malignant melanoma. Dermatol Surg 1995; 21:979-983
30. Morton DL, Wen DR, Foshag LJ, Essner R, Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J ClinOncol 1993; 11:1751-1756
31. Abbott KL, Harman GS. Combination chemotherapy for disseminated malignant melanoma. Anticancer Drugs 1995; 6:489-497
32. Meyskens FL Jr, Kopecky KJ, Taylor CW, Noyés RD, Tuthill RJ, Hersh EM, et al. Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study. J Natl Cancer Inst 1995; 87:1710-1713
33. Burmeister BH, Smithers BM, Poulsen M, McLeod GR, Bryant G, Tripcony L, et al. Radiation therapy for nodal disease in malignant melanoma. World J Surg 1995; 19:369371
34. Bystryn JC. Clinical activity of a polyvalent melanoma antigen vaccine. Recent Results Cancer Res 1995; 139:337-348
35. Romero JB, Stefanato CM, Kopf AW, Bart RS. Follow-up recommendations for patients with stage I malignant melanoma. J Dermatol Surg Oncol 1994; 20:175-178